Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Emergence Delirium 1Delirium 1Colorectal Neoplasms 1Cachexia 1Biliary Tract Neoplasms 1

Interventions

Cisplatin 8Carboplatin 8Bevacizumab 8Pleurodesis 7Talc 6Paclitaxel 6Docetaxel 5Povidone-Iodine 4Doxycycline 4Thoracoscopy 3Taxes 3Gemcitabine 3Drug Therapy 3Chest Tubes 3aldesleukin 2Zoledronic Acid 2Trastuzumab 2Thoracentesis 2Surveys and Questionnaires 2Sodium Chloride 2Silver Nitrate 2Pharmaceutical Preparations 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2High-Energy Shock Waves 2Fluorodeoxyglucose F18 2Fentanyl 2Erlotinib Hydrochloride 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion, Malignant × Ibuprofen × Thoracic × Clear all
NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡